Cite
MLA Citation
Chang-Ting Lin et al.. “First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis.” Journal of immunotherapy, vol. 45, no. 9, 2022, pp. 407–414. http://access.bl.uk/ark:/81055/vdc_100167545230.0x00000e